Smokeless Tobacco Treatment Market Research Report – Global Forecast till 2027

Global Smokeless Tobacco treatment market research report, by type (chewing tobacco, snuff/dipping tobacco, dissolvable tobacco, Varenicline), treatment (nicotine replacement therapy, medication), end user (hospitals & clinics)– Forecast till 2027

ID: MRFR/HC/5662-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global smokeless tobacco treatment market is expected to register a CAGR of 6.8% during the forecast period of 2018 to 2023.


Smokeless tobacco is a type of tobacco that is not smoked or burned. Smokeless tobacco can be exampled by chewing tobacco, moist snuff, and dissolvable tobacco (neither of these forms is considered safe). It is reportable that ~28 chemicals including nitrosamines, polonium, polynuclear aromatic hydrocarbons, and others found in smokeless tobacco can cause cancer (oral cancer, oesophageal cancer, and pancreatic cancer). Moreover, the problem of addiction persists within the consumers.


From the past few years, the consumption of the smokeless tobacco has increased, resulting in parallel rise of associate health problems. According to the facts sheet- “Smokeless Tobacco Use in the United States” published by the Centres for Disease Control and Prevention in 2016, ~3 in 100 adults, i.e., 3.4% of the US adults used smokeless tobacco. Similar usage pattern is estimated across the globe, paving a way for the market to develop and grow during the forecast period. Moreover, as per a study published in 2016 by the American Journal of Epidemiology stated that the prevalence of head and neck cancer in the consumers of smokeless tobacco is high. The study further estimated that the prevalence of the head and neck cancer for smokeless tobacco consumers was about 1.7%.


Conclusively, factors such as growing FDA drug approvals against smokeless tobacco, increasing adoption of nicotine patch, and strong clinical pipeline along with rising consumption of smokeless tobacco is estimated to drive the market growth during the forecast period. However, limited availability of the products, changing regulatory framework and lack of awareness for smokeless tobacco treatments restraints the market growth.


Segmentation


The global smokeless tobacco treatment market is segmented based on type, treatment, end user and region.


The global market for smokeless tobacco treatment, by type is segmented into chewing tobacco, snuff/dipping tobacco, dissolvable tobacco. The market by treatment segment is divided into nicotine replacement therapy, medication, and psychological and behavioural treatments. Based on end-user, the market is segmented into hospitals & clinics, academic & research organizations, and pharmacies


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely- the Americas, Europe, Asia-Pacific and the Middle East & African region.


Regional Market Summary


Global Smokeless tobacco treatment market Share (%), by Region, 2017


 Sources:


The Americas dominated the global market for smokeless tobacco treatment owing to increasing therapeutics demands for smokeless tobacco related diseases, presence of major market players and developed economies like US and Canada within the region.


In 2017, it was estimated that Europe stood second in the global smokeless tobacco treatment market. This can be attributed to the high consumption of smokeless tobacco within the region and changing lifestyle changes. A recent article published by the Tobacco Atlas stated that in 2013, more than 2% of the total population residing within Germany used smokeless tobacco. Moreover, presence of developed economies like UK, Germany, France, and others within the region boosts the market growth.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing government’s support for foreign investments drives the regional markets of the Asia Pacific region. According to a report published by the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to grow at a CAGR of 22.87 and reach USD 280 billion by 2020.


On the other hand, the Middle East and Africa held least share in the global smokeless tobacco treatment market due to the presence of poor economies and low per capita income, especially within the African region. The Middle Eastern region is estimated to be a major market for the Middle East and African region.


Key players


Some of the key players in the global smokeless tobacco treatment market are Pfizer Inc., GlaxoSmithKline plc., Johnson & Johnson Services Inc., Novartis, Cigna, Yesmoke, Habitrol, Perrigo Co. Plc., Cambrex Corporation, Fertin Pharma, Veracyte, Inc. and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the smokeless tobacco treatment. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience:



  • Pharmaceutical companies

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers

  • Clinical Research Organizations


Market Segmentation and Key Market Players:


Global Smokeless Tobacco Treatment Market, by Type:



  • Chewing Tobacco

  • Snuff/Dipping Tobacco

  • Dissolvable Tobacco


Global Smokeless Tobacco Treatment Market, by Treatment:



  • Nicotine Replacement Therapy

    • Nicotine Patch

    • Nicotine Gum

    • Nicotine Sprays



  • Medication

    • Varenicline

    • Bupropion



  • Psychological and Behavioral Treatments

    • Hypnotherapy

    • Cognitive-Behavioral Therapy

    • Others




Global Smokeless Tobacco Treatment Market, by End User:



  • Hospitals & Clinics

  • Academic & Research Organizations

  • Pharmacies


 



Frequently Asked Questions (FAQ) :


Smokeless tobacco treatment market is projected to grow at a 6.8% CAGR between 2018-2023.

The Americas is expected to lead the smokeless tobacco treatment market.

Increasing FDA drug approvals and strong clinical pipeline are the key factors driving the smokeless tobacco treatment market.

Lack of awareness and changing regulatory framework may limit the smokeless tobacco treatment market.

Eminent players profiled in the smokeless tobacco treatment market include Veracyte, Inc, Fertin Pharma, Cambrex Corporation, Perrigo Co. Plc., Habitrol, Yesmoke, Cigna, Novartis, Johnson & Johnson Services Inc., GlaxoSmithKline plc., and Pfizer Inc.

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Smokeless Tobacco Treatment Market, by Type

6.1 Introduction

6.2 Chewing Tobacco

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Snuff/Dipping Tobacco

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Dissolvable Tobacco

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Smokeless Tobacco Treatment Market, by Treatment

7.1 Introduction

7.2 Nicotine Replacement Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1 Nicotine Patch

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Nicotine Gum

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3 Nicotine Sprays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Medication

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.1 Varenicline

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Bupropion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Psychological and Behavioural Treatments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.1 Hypnotherapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2 Cognitive-Behavioral Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.3 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Smokeless Tobacco Treatment Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Academic & Research Organizations

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Smokeless Tobacco Treatment Market , by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer Inc.

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 GlaxoSmithKline plc.

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Johnson & Johnson Services Inc.

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Novartis

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cigna

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Yesmoke

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Habitrol

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Perrigo Co. Plc.

11.8.1 Overview

11.8.2 Type/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Cambrex Corporation

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Fertin Pharma

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Veracyte, Inc.

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Smokeless Tobacco Treatment Market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Smokeless Tobacco Treatment Market Synopsis, 2020-2027

Table 2 Smokeless Tobacco Treatment Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Smokeless Tobacco Treatment Market , by Region, 2020-2027(USD Million)

Table 4 Smokeless Tobacco Treatment Market , by Type, 2020-2027(USD Million)

Table 5 Smokeless Tobacco Treatment Market , by Treatment, 2020-2027(USD Million)

Table 6 Smokeless Tobacco Treatment Market , End User, 2020-2027(USD Million)

Table 7 North America: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 8 North America: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 9 North America: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 10 US: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 11 US: Smokeless Tobacco Treatment Market , by Treatment, 2020-2027(USD Million)

Table 12 US: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 13 Canada: Smokeless Tobacco Treatment Market,by Type, 2020-2027(USD Million)

Table 14 Canada: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 15 Canada: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 16 South America: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 17 South America: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 18 South America: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 19 Europe: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 20 Europe: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 21 Europe: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 22 Western Europe: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 23 Western Europe: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 24 Western Europe: Smokeless Tobacco Treatment Market, by End User, 2020-2027(USD Million)

Table 25 Eastern Europe: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 26 Eastern Europe: Smokeless Tobacco Treatment Market, by Treatment, 2020-2027(USD Million)

Table 27 Eastern Europe: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 28 Asia-Pacific: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 29 Asia-Pacific: Smokeless Tobacco Treatment Market , by Treatment, 2020-2027(USD Million)

Table 30 Asia-Pacific: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

Table 31 Middle East & Africa: Smokeless Tobacco Treatment Market, by Type, 2020-2027(USD Million)

Table 32 Middle East & Africa: Smokeless Tobacco Treatment Market , by Treatment, 2020-2027(USD Million)

Table 33 Middle East & Africa: Smokeless Tobacco Treatment Market, End User, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Smokeless Tobacco Treatment Market

Figure 3 Market Dynamics for Smokeless Tobacco Treatment Market

Figure 4 Smokeless Tobacco Treatment Market Share, by Type, 2020

Figure 5 Smokeless Tobacco Treatment Market Share, by Treatment, 2020

Figure 6 Smokeless Tobacco Treatment Market Share, End User, 2020

Figure 7 Smokeless Tobacco Treatment Market Share, by Region, 2020

Figure 8 North America: Smokeless Tobacco Treatment Market Share, by Country, 2020

Figure 9 Europe: Smokeless Tobacco Treatment Market Share, by Country, 2020

Figure 10 Asia-Pacific: Smokeless Tobacco Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Smokeless Tobacco Treatment Market Share, by Region, 2020

Figure 12 Smokeless Tobacco Treatment Market : Company Share Analysis, 2020 (%)

Figure 13 Pfizer Inc.: Key Financials

Figure 14 Pfizer Inc.: Segmental Revenue

Figure 15 Pfizer Inc.: Geographical Revenue

Figure 16 GlaxoSmithKline plc.: Key Financials

Figure 17 GlaxoSmithKline plc.: Segmental Revenue

Figure 18 GlaxoSmithKline plc.: Geographical Revenue

Figure 19 Johnson & Johnson Services Inc.: Key Financials

Figure 20 Johnson & Johnson Services Inc.: Segmental Revenue

Figure 21 Johnson & Johnson Services Inc.: Geographical Revenue

Figure 22 Novartis: Key Financials

Figure 23 Novartis: Segmental Revenue

Figure 24 Novartis: Geographical Revenue

Figure 25 Cigna: Key Financials

Figure 26 Cigna: Segmental Revenue

Figure 27 Cigna: Geographical Revenue

Figure 28 Yesmoke: Key Financials

Figure 29 Yesmoke: Segmental Revenue

Figure 30 Yesmoke: Geographical Revenue

Figure 31 Habitrol: Key Financials

Figure 32 Habitrol: Segmental Revenue

Figure 33 Habitrol: Geographical Revenue

Figure 34 Perrigo Co. Plc.: Key Financials

Figure 35 Perrigo Co. Plc.: Segmental Revenue

Figure 36 Perrigo Co. Plc.: Geographical Revenue

Figure 37 Cambrex Corporation: Key Financials

Figure 38 Cambrex Corporation: Segmental Revenue

Figure 39 Cambrex Corporation: Geographical Revenue

Figure 40 Fertin Pharma: Key Financials

Figure 41 Fertin Pharma: Segmental Revenue

Figure 42 Fertin Pharma: Geographical Revenue

Figure 43 Veracyte, Inc.: Key Financials

Figure 44 Veracyte, Inc.: Segmental Revenue

Figure 45 Veracyte, Inc.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.